RadNet (RDNT) Aandeel Koers
RadNet Koers
In de afgelopen 19 jaar liet RadNet de omzet jaarlijks met 14,3% groeien tot 2,04 Miljard USD. De winst per aandeel is de afgelopen 13 jaar met 11,9% per jaar gedaald. Bij RadNet is de nettowinstmarge met -0,9% ten opzichte van 1,9% enkele jaren geleden gedaald. Het consensus-koersdoel voor RadNet op 12 maanden bedraagt 78,00 USD, circa 11,1% boven de huidige koers. Van de 14 analisten geven 13 het aandeel een koopadvies — per saldo een Kopen-consensus.
RadNet aandeelkoers
RadNet bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over RadNet
RadNet Inc, a leading provider of outpatient diagnostic imaging services, operates an extensive network of imaging centers across the United States. The company's business model revolves around offering a comprehensive range of high-quality imaging services, including MRI, CT scans, ultrasound, and more. RadNet strives to be at the forefront of medical imaging technology and delivers prompt, accurate results to healthcare providers and patients alike. By leveraging its advanced technology, vast infrastructure, and skilled medical professionals, RadNet Inc remains committed to delivering exceptional diagnostic imaging services to enhance patient care and improve overall health outcomes.
RadNet Inc is primarily active in the healthcare services industry.
RadNet Inc faces competition from various players in the market. Some of the main competitors include vRad, Inc., Alliance HealthCare Services, Inc., and Sonic Healthcare Limited. These companies also operate in the medical diagnostics and imaging services industry, offering similar services as RadNet Inc. Competing for market share and customers, RadNet Inc faces challenges in staying ahead of these key adversaries. As technology and innovation continue to shape the industry, RadNet Inc must remain proactive in its strategies to maintain a strong position in the market.
RadNet Inc. is a leading provider of high-quality, cost-effective diagnostic imaging services in the United States. Established in 1981, RadNet has grown to become a trusted name in the healthcare industry. With a network of over 330 outpatient imaging centers, RadNet offers a wide range of imaging services, including MRI, CT scans, X-rays, mammography, and more. The company is dedicated to delivering accurate and timely results to physicians and patients, helping in the early detection and diagnosis of diseases. RadNet continues to innovate and expand its services, making a positive impact on patient care across the nation.
RadNet Inc has achieved several significant milestones. Continuously expanding its network, RadNet has acquired multiple imaging centers across the United States, enhancing its diagnostic and treatment capabilities. The company has also developed innovative technologies and services, establishing itself as a leader in the field of outpatient diagnostic imaging. RadNet has successfully implemented integrated radiology information systems and picture archiving communication systems, improving operational efficiency and patient care. By consistently delivering high-quality imaging services, RadNet has garnered a strong reputation for its commitment to excellence. The company's dedication to advancing medical imaging technologies and expanding access to affordable healthcare has further solidified its position as a prominent player in the industry.
RadNet Inc is primarily present in the United States of America. With its headquarters in California, the company operates a network of outpatient imaging centers across various states. It has a significant presence in states like California, Maryland, New Jersey, New York, and Delaware, providing diagnostic imaging services to patients. RadNet Inc's expansive reach and strategic locations enable it to deliver high-quality imaging services to a wide range of individuals across different regions in the United States.
RadNet Inc represents values of excellence, innovation, and patient-centered care. Their corporate philosophy revolves around providing high-quality, comprehensive diagnostic imaging services to enhance patient outcomes. As a leading national provider of outpatient imaging, RadNet focuses on leveraging advanced technology and expertise to deliver accurate and timely results. By emphasizing patient satisfaction and quality assurance, RadNet Inc ensures their services are reliable, efficient, and accessible. With a commitment to continuous improvement and staying at the forefront of medical advancements, RadNet Inc remains dedicated to delivering exceptional healthcare experiences to patients across the United States.
Analisten hanteren momenteel een gemiddeld koersdoel van 78,00 USD voor het aandeel RadNet (mediaan: 78,00 USD), oftewel +11,1 % ten opzichte van de laatste koers. De consensus is gebaseerd op 14 analistenratings.
14 analisten beoordelen het aandeel RadNet momenteel: 13 adviseren kopen, 1 houden en 0 verkopen. Voor 2026 verwachten analisten dat RadNet een omzet van 2,51 Miljard USD en winst per aandeel van 0,51 USD behaalt.
Omgezet tegen de huidige wisselkoers noteert het aandeel RadNet op 62,67 EUR (70,23 USD).
Het aandeel RadNet (RDNT) is genoteerd aan 3 beurzen, waaronder: NASDAQ (RDNT), SIX (Zürich) (PQIA.SW), Frankfurt (PQIA.F).
RadNet Inc is a leading company in medical imaging and diagnosis, offering a wide range of services in various areas. The company operates and owns a network of radiology clinics and diagnostic centers in the United States, known for its high quality and reliability in disease diagnosis, treatment, and prevention. RadNet operates in three main business areas: medical imaging, oncology, and radiology information systems. Medical imaging is one of RadNet's key business areas, focusing on diagnostic imaging services such as mammography, x-rays, CT scans, MRI scans, ultrasound, and oncologic imaging services for cancer and other diseases diagnosis. Oncology is another important business area for RadNet, offering advanced radiation therapy and medical oncology services for cancer treatment. Through partnerships and acquisitions of other companies, RadNet also has access to all major therapy options and technologies in oncology. Radiology information systems are another important business area for RadNet, focusing on developing efficient and innovative systems for managing images, reports, and patient data. The company also provides training and consulting services for the implementation of radiology information systems, as well as customizable software solutions for healthcare facilities. In addition to its core business areas, RadNet also offers specialized products and services, such as radiology software for image processing, online referral services for patients, and online diagnostic services to support specialists. RadNet operates over 340 locations and employs over 8,100 staff. The company is committed to providing high-quality healthcare at fair prices, making it a preferred provider for healthcare facilities, insurance companies, and patients in many regions of the USA. RadNet's business model is based on the goal of playing a leading role in global medical imaging and diagnosis through investments in innovative technologies, partnerships, and acquisitions of companies, as well as improving healthcare delivery. RadNet also seeks to expand the clinical knowledge and experience of its staff to further enhance the quality of services offered. Through training and professional development, the personnel will be able to utilize the latest diagnostic and treatment methods, providing optimal care for patients. In summary, RadNet's business model aims to offer a wide range of services in medical imaging and diagnosis to enhance disease diagnosis and treatment. The company strives to gain a competitive advantage and improve patient well-being through investments in innovative technologies and partnerships with other companies, as well as investments in training and professional development for its staff.
De verwachte omzet van RadNet bedraagt 2,51 Miljard USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De verwachte winst van RadNet bedraagt 38,45 Miljoen USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van RadNet bedraagt momenteel 137,34. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het RadNet-aandeel in te schatten.
De koers-omzetverhouding (P/S) van RadNet bedraagt momenteel 2,10. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het RadNet-aandeel.
De Eulerpool Kwaliteitsscore voor RadNet is 4/10.
De ISIN van RadNet is US7504911022. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van RadNet is A0LFMZ. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van RadNet is RDNT. Onder dit beurstickersymbool wordt het RadNet-aandeel op de beurs verhandeld.
RadNet aandeel
RadNet Peer Group
RadNet Ticker
RadNet FIGI
Alle fundamentals en diepgaande analyse van RadNet
Onze aandelenanalyse van het RadNet-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van RadNet. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: